These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20420408)

  • 1. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
    Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
    J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.
    Holbourn KP; Shone CC; Acharya KR
    FEBS J; 2006 Oct; 273(20):4579-93. PubMed ID: 16956368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
    Han S; Tainer JA
    Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.
    Han S; Craig JA; Putnam CD; Carozzi NB; Tainer JA
    Nat Struct Biol; 1999 Oct; 6(10):932-6. PubMed ID: 10504727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
    Ruf A; de Murcia G; Schulz GE
    Biochemistry; 1998 Mar; 37(11):3893-900. PubMed ID: 9521710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of ADP-Ribosylating Bacterial Toxins.
    Chen C; Barbieri JT
    Methods Mol Biol; 2018; 1813():287-295. PubMed ID: 30097876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
    Ruf A; Rolli V; de Murcia G; Schulz GE
    J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages.
    Domenighini M; Rappuoli R
    Mol Microbiol; 1996 Aug; 21(4):667-74. PubMed ID: 8878030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif.
    Tao Z; Gao P; Hoffman DW; Liu HW
    Biochemistry; 2008 May; 47(21):5804-13. PubMed ID: 18452307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the Clostridium limosum C3 exoenzyme.
    Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
    FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
    Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
    J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus sphaericus mosquitocidal toxin (MTX) and pierisin: the enigmatic offspring from the family of ADP-ribosyltransferases.
    Carpusca I; Jank T; Aktories K
    Mol Microbiol; 2006 Nov; 62(3):621-30. PubMed ID: 17076664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
    Yates SP; Taylor PL; Jørgensen R; Ferraris D; Zhang J; Andersen GR; Merrill AR
    Biochem J; 2005 Feb; 385(Pt 3):667-75. PubMed ID: 15458385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual conformation of nicotinamide adenine dinucleotide (NAD) bound to diphtheria toxin: a comparison with NAD bound to the oxidoreductase enzymes.
    Bell CE; Yeates TO; Eisenberg D
    Protein Sci; 1997 Oct; 6(10):2084-96. PubMed ID: 9336832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse T cell membrane proteins Rt6-1 and Rt6-2 are arginine/protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins.
    Koch-Nolte F; Petersen D; Balasubramanian S; Haag F; Kahlke D; Willer T; Kastelein R; Bazan F; Thiele HG
    J Biol Chem; 1996 Mar; 271(13):7686-93. PubMed ID: 8631807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
    Vogelsgesang M; Aktories K
    Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling and molecular dynamics studies of a novel C3-like ADP-ribosyltransferase.
    Xiao JF; Li ZS; Sun CC
    Bioorg Med Chem; 2004 May; 12(9):2035-41. PubMed ID: 15080907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.